Soft pastels · Free shipping over $75 · Shop the boutique
Login Register
glp-1 receptor agonist use and risk of suicide death

glp-1 receptor agonist use and risk of suicide death Glucagon-like peptide-1 agonists substance disorders among US veterans with type 2 diabetes: cohort study Benefit-Risk Assessment of GLP-1 Receptor

SKU: 78062069981

4.6
USD26.35 USD58.35

Pay in 4 interest-free payments of $6.59 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Lancet Oncol 19 (4): 510-520, 2018

glp-1 receptor agonist use and risk of suicide death Glucagon-like peptide-1 agonists substance disorders among US veterans with type 2 diabetes: cohort study Benefit-Risk Assessment of GLP-1 Receptor

Shipping from Thailand via Standard Intl Airmail with Tracking Number

glp-1 receptor agonist use and risk of suicide death Glucagon-like peptide-1 agonists substance disorders among US veterans with type 2 diabetes: cohort study Benefit-Risk Assessment of GLP-1 Receptor

A.WinshipA.MenkhorstE.NieG.GargettC

glp-1 receptor agonist use and risk of suicide death Glucagon-like peptide-1 agonists substance disorders among US veterans with type 2 diabetes: cohort study Benefit-Risk Assessment of GLP-1 Receptor

Sharifi, M., Moridnia, A., Mortazavi, D., Salehi, M., Bagheri, M., & Sheikhi, A

glp-1 receptor agonist use and risk of suicide death Glucagon-like peptide-1 agonists substance disorders among US veterans with type 2 diabetes: cohort study Benefit-Risk Assessment of GLP-1 Receptor
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products